Biopsy Devices Market - United States

Market Statistics

Market Size in 2023: USD 934.3 Million

Market Forecast in 2032: USD 1,244.9 Million

Market Growth Rate: 3.14% (2024-2032)

The U.S. biopsy devices market is expanding rapidly, driven by advancements in medical technology and increasing demand for minimally invasive procedures. This growth is fueled by the growing focus on early diagnosis and personalized medicine. According to the latest report by IMARC Group, the market is projected to grow at a CAGR of 3.14% from 2024 to 2032.

Download sample copy of the Report: https://www.imarcgroup.com/united-states-biopsy-devices-market/requestsample

United States Biopsy Devices Industry Trends and Drivers:

Market Trends

• Advancements in Minimally Invasive Procedures:

• • Development of new imaging technologies enhances precision in biopsy procedures.
  • Reduced invasiveness improves patient comfort and diagnostic outcomes.

• Adoption of Robotic-Assisted Biopsy Systems:

• • Increasing use of robotics provides greater accuracy and consistency in tissue sampling.

• Rise of Disposable Biopsy Devices:

• • Convenience and reduced risk of contamination drive their popularity.

• Preference for Needle-Based Biopsy Methods:

• • High-quality samples with minimal patient discomfort.

• Focus on Faster and More Accurate Diagnoses:

• • Innovations contribute to improved diagnostic workflows in healthcare settings.

Market Drivers

• Rising Prevalence of Cancer and Chronic Diseases:

• • Increased demand for precise diagnostic methods.
  • Biopsy devices play a crucial role in early detection and treatment planning.

• Emphasis on Early Disease Detection:

• • Public health initiatives and patient education boost routine screening participation.
  • Higher biopsy volumes drive market growth.

• Technological Advancements:

• • Vacuum-assisted and image-guided systems improve accuracy and procedural efficiency.
  • Healthcare providers prefer these systems for their reliability and minimal invasiveness.

• Aging Population:

• • Older adults’ higher risk for cancer and other conditions increases biopsy demand.
  • Steady growth in biopsy procedures supports market expansion.

Other Supporting Factors

• Improved Healthcare Infrastructure:

• • Enhanced access to advanced diagnostic tools in various healthcare settings.

• Focus on Optimized Patient Care:

• • Efficient and minimally invasive diagnostic solutions attract healthcare providers.

• Government and Private Sector Investments:

• • Support for innovative medical technologies fuels market development.

United States Biopsy Devices Industry Segmentation:

The market report offers a comprehensive analysis of the segments, highlighting those with the largest U.S. biopsy devices market share. It includes forecasts for the period 2024-2032 and historical data from 2018-2023 for the following segments.

The report has segmented the market into the following categories:

Breakup by Procedure Type:

• Surgical Biopsy
• Needle Biopsy

Breakup by Product:

• Biopsy Guidance Systems
• Needle Based Biopsy Guns
• Biopsy Needles
• Biopsy Forceps
• Others

Breakup by Application:

• Breast Biopsy
• Lung Biopsy
• Colorectal Biopsy
• Prostate Biopsy
• Others

Breakup by Guidance Technique:

• Ultrasound-guided Biopsy
• Stereotactic-guided Biopsy
• MRI-guided Biopsy
• Others

Breakup by End User:

• Hospitals and Clinics
• Academic and Research Institutes
• Others

Breakup by Region:

• Northeast
• Midwest
• South
• West

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players.

Request for customization: https://www.imarcgroup.com/request?type=report&id=3212&flag=F

Key highlights of the Report:

• Market Performance (2018-2023)
• Market Outlook (2024-2032)
• COVID-19 Impact on the Market
• Porter’s Five Forces Analysis
• Strategic Recommendations
• Historical, Current and Future Market Trends
• Market Drivers and Success Factors
• SWOT Analysis
• Structure of the Market
• Value Chain Analysis
• Comprehensive Mapping of the Competitive Landscape

Note: If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.

About Us:

IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services.  IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.

Contact Us:  

IMARC Group 

134 N 4th St. Brooklyn, NY 11249, USA 

Email: [email protected] 

Tel No:(D) +91 120 433 0800 

United States: +1-631-791-1145